Amenorrhea differential diagnosis: Difference between revisions

	Amenorrhea Microchapters
Home
Patient Information Primary amenorrhea Secondary amenorrhea
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Amenorrhea from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Amenorrhea differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Amenorrhea differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Amenorrhea differential diagnosis
CDC on Amenorrhea differential diagnosis
Amenorrhea differential diagnosis in the news
Blogs on Amenorrhea differential diagnosis
Directions to Hospitals Treating Amenorrhea
Risk calculators and risk factors for Amenorrhea differential diagnosis

VisualWikitext

Revision as of 14:38, 25 September 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Differentiating Diseases with Amenorrhea from each other

As amenorrhea manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. Primary amenorrhea must be differentiated from other diseases that cause lack of menstrual cycle, such as [differential dx1] and [differential dx2]. In contrast, secondary amenorrhea must be differentiated from other diseases that cause menstrual cycle arrest, such as [differential dx3] and [differential dx4].

Group	Diseases	Laboratory Findings										Physical Examination				Other Findings
Group	Diseases	Estrogen	Progesterone	GnRH	LH	FSH	Androgen	TSH	T4	PRL	Karyotype	Genitalia	Breast development	Pubic hair	Uterus	Other Findings
Primary amenorrhea	Mullerian agenesis^[1]					+
	3-beta-hydroxysteroid dehydrogenase type 2 deficiency	↑					-
	Androgen insensitivity syndrome^[2]				↓
	Kallmann syndrome^[3]
	Turner syndrome^[4]
	17-alpha-hydroxylase deficiency
Secondary amenorrhea	Primary ovarian insufficiency^[5]
	Hypothyroidism^[6]
	Hyperprolactinemia^[7]
	Polycystic ovary syndrome^[8]
	Asherman's syndrome^[9]

Physiologic
Hypothalamic
- Structural
  Craniopharyngioma
  
  Lymphoma
  
  Sarcoidosis
  
  Hemochromatosis
- Functional
  Anorexia/bulimia
  
  Excessive exercise/weight loss
  
  Stress
Pituitary
- Secretory tumors
  Prolactinoma
  
  Cushing’s disease
  
  Acromegaly
- Destructive lesions
  Non-functional tumors
  
  Sheehan's syndrome
  
  Hemochromatosis
Ovarian
- Premature ovarian failure
- Hyperandrogenic disorders
  Polycystic ovary syndrome (PCOS)
  
  Nonclassical congenital adrenal hyperplasia (NCCAH)
  
  Adrenal/ovarian androgen-secreting tumors
Anatomic
- Destruction of uterine cavity
  Asherman’s syndrome
  
  Tuberculosis (TB)
Other
- Hyperthyroidism/hypothyroidism
- Cushing’s syndrome

Diseases that cause primary amenorrhea in females:^[10]^[11]^[12]^[13]^[14]^[15]^[16]^[17]

Disease name	Cause	Differentiating
Disease name	Cause	Findings	Uterus	Breast development	Testosterone	LH	FSH	Karyotyping
3-beta-hydroxysteroid dehydrogenase type 2 deficiency	HSD3B2 gene mutation	Undervirilization in 46,XY individuals due to a block in testosterone biosynthesis Mild virilization in 46,XX individuals	Yes in female	Yes in female	Low	Normal	Normal	XY and XX
17-alpha-hydroxylase deficiency	CYP17A1 gene mutation	Female external genitalia Primary amenorrhea Hypertension Absence of secondary sexual characteristics Minimal body hair	No	No	Low	Normal	Normal	XY
Gonadal dysgenesis	Mutations: SRY FOG2/ZFPM2 WNT1	Female external genitalia Intact Mullerian ducts Streak gonads karyotyping	Yes	Yes	Low	High	High	XY
Testicular regression syndrome	Loss of testicular function and tissue early in development	Female phenotype with atrophic Mullerian ducts	No	No	Low	High	High	XY
LH receptor defects	LH receptor gene mutation on chromosome 2	Female external genitalia Lack a uterus and fallopian tubes Epididymis and vas deferens may be present Laboratory: Unresponsiveness to hCG Normal levels of testosterone precursors (produced in the adrenal glands)	No	No	Low	High	High	XY
5-alpha-reductase type 2 deficiency	Autosomal recessive	Female external genitalia or ambiguous Bilateral testes and normal testosterone formation Impaired external virilization during embryogenesis Defective conversion of testosterone to DHT Testosterone to DHT ratio is >10:1	No	No	Normal male range	High to normal	High to normal	XY
Androgen insensitivity syndrome	Androgen receptor defect	Female external genitalia Resistant to testosterone	No	Yes	Normal male range	Normal	Normal	XY
Mullerian agenesis	Mutations in WNT4	Normal female genitalia Normal breast development	No	Yes	Normal female range	Normal	Normal	XX
Primary ovarian insufficiency	Genetic defects such as turner syndrome, fragile X syndrome, and other chromosomal defects	Normal female genitalia	Yes	Yes	Normal female range	High	High	XX
Hypogonadotropic hypogonadism	Functional, sellar masses	Normal female genitalia, Delayed puberty	Yes	No	Normal female range	Low	Normal	XX
Turner syndrome	Chromosomal	Female external genitalia	Yes	Yes	Normal female range	High	High	45 XO

References

↑ Folch M, Pigem I, Konje JC (2000). "Müllerian agenesis: etiology, diagnosis, and management". Obstet Gynecol Surv. 55 (10): 644–9. PMID 11023205.
↑ "Current evaluation of amenorrhea". Fertil. Steril. 82 (1): 266–72. 2004. doi:10.1016/j.fertnstert.2004.02.098. PMID 15237040.
↑ Albanese A, Stanhope R (1995). "Investigation of delayed puberty". Clin. Endocrinol. (Oxf). 43 (1): 105–10. PMID 7641400.
↑ Sybert VP, McCauley E (2004). "Turner's syndrome". N. Engl. J. Med. 351 (12): 1227–38. doi:10.1056/NEJMra030360. PMID 15371580.
↑ Nelson LM (2009). "Clinical practice. Primary ovarian insufficiency". N. Engl. J. Med. 360 (6): 606–14. doi:10.1056/NEJMcp0808697. PMC 2762081. PMID 19196677.
↑ Kalro BN (2003). "Impaired fertility caused by endocrine dysfunction in women". Endocrinol. Metab. Clin. North Am. 32 (3): 573–92. PMID 14575026.
↑ Pickett CA (2003). "Diagnosis and management of pituitary tumors: recent advances". Prim. Care. 30 (4): 765–89. PMID 15024895.
↑ "ACOG practice bulletin clinical management guidelines for obstetrician-gynecologists. Number 40, November 2002". Obstet Gynecol. 100 (5 Pt 1): 1045–50. 2002. PMID 12434783.
↑ Fritz, Marc (2011). Clinical gynecologic endocrinology and infertility. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. ISBN 978-0781779685.
↑ Maimoun L, Philibert P, Cammas B, Audran F, Bouchard P, Fenichel P, Cartigny M, Pienkowski C, Polak M, Skordis N, Mazen I, Ocal G, Berberoglu M, Reynaud R, Baumann C, Cabrol S, Simon D, Kayemba-Kay's K, De Kerdanet M, Kurtz F, Leheup B, Heinrichs C, Tenoutasse S, Van Vliet G, Grüters A, Eunice M, Ammini AC, Hafez M, Hochberg Z, Einaudi S, Al Mawlawi H, Nuñez CJ, Servant N, Lumbroso S, Paris F, Sultan C (2011). "Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients". J. Clin. Endocrinol. Metab. 96 (2): 296–307. doi:10.1210/jc.2010-1024. PMID 21147889.
↑ Moreira AC, Leal AM, Castro M (1990). "Characterization of adrenocorticotropin secretion in a patient with 17 alpha-hydroxylase deficiency". J. Clin. Endocrinol. Metab. 71 (1): 86–91. doi:10.1210/jcem-71-1-86. PMID 2164530.
↑ Heremans GF, Moolenaar AJ, van Gelderen HH (1976). "Female phenotype in a male child due to 17-alpha-hydroxylase deficiency". Arch. Dis. Child. 51 (9): 721–3. PMC 1546244. PMID 999330.
↑ Biglieri EG (1979). "Mechanisms establishing the mineralocorticoid hormone patterns in the 17 alpha-hydroxylase deficiency syndrome". J. Steroid Biochem. 11 (1B): 653–7. PMID 226795.
↑ Saenger P (1996). "Turner's syndrome". N. Engl. J. Med. 335 (23): 1749–54. doi:10.1056/NEJM199612053352307. PMID 8929268.
↑ Bastian C, Muller JB, Lortat-Jacob S, Nihoul-Fékété C, Bignon-Topalovic J, McElreavey K, Bashamboo A, Brauner R (2015). "Genetic mutations and somatic anomalies in association with 46,XY gonadal dysgenesis". Fertil. Steril. 103 (5): 1297–304. doi:10.1016/j.fertnstert.2015.01.043. PMID 25813279.
↑ Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE (1974). "Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism". Science. 186 (4170): 1213–5. PMID 4432067.
↑ Schnitzer JJ, Donahoe PK (2001). "Surgical treatment of congenital adrenal hyperplasia". Endocrinol. Metab. Clin. North Am. 30 (1): 137–54. PMID 11344932.

Template:WH Template:WS

[pmid11023205-1] Folch M, Pigem I, Konje JC (2000). "Müllerian agenesis: etiology, diagnosis, and management". Obstet Gynecol Surv. 55 (10): 644–9. PMID 11023205.

[pmid15237040-2] "Current evaluation of amenorrhea". Fertil. Steril. 82 (1): 266–72. 2004. doi:10.1016/j.fertnstert.2004.02.098. PMID 15237040.

[pmid7641400-3] Albanese A, Stanhope R (1995). "Investigation of delayed puberty". Clin. Endocrinol. (Oxf). 43 (1): 105–10. PMID 7641400.

[pmid15371580-4] Sybert VP, McCauley E (2004). "Turner's syndrome". N. Engl. J. Med. 351 (12): 1227–38. doi:10.1056/NEJMra030360. PMID 15371580.

[pmid19196677-5] Nelson LM (2009). "Clinical practice. Primary ovarian insufficiency". N. Engl. J. Med. 360 (6): 606–14. doi:10.1056/NEJMcp0808697. PMC 2762081. PMID 19196677.

[pmid14575026-6] Kalro BN (2003). "Impaired fertility caused by endocrine dysfunction in women". Endocrinol. Metab. Clin. North Am. 32 (3): 573–92. PMID 14575026.

[pmid15024895-7] Pickett CA (2003). "Diagnosis and management of pituitary tumors: recent advances". Prim. Care. 30 (4): 765–89. PMID 15024895.

[pmid12434783-8] "ACOG practice bulletin clinical management guidelines for obstetrician-gynecologists. Number 40, November 2002". Obstet Gynecol. 100 (5 Pt 1): 1045–50. 2002. PMID 12434783.

[9] Fritz, Marc (2011). Clinical gynecologic endocrinology and infertility. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. ISBN 978-0781779685.

[pmid21147889-10] Maimoun L, Philibert P, Cammas B, Audran F, Bouchard P, Fenichel P, Cartigny M, Pienkowski C, Polak M, Skordis N, Mazen I, Ocal G, Berberoglu M, Reynaud R, Baumann C, Cabrol S, Simon D, Kayemba-Kay's K, De Kerdanet M, Kurtz F, Leheup B, Heinrichs C, Tenoutasse S, Van Vliet G, Grüters A, Eunice M, Ammini AC, Hafez M, Hochberg Z, Einaudi S, Al Mawlawi H, Nuñez CJ, Servant N, Lumbroso S, Paris F, Sultan C (2011). "Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients". J. Clin. Endocrinol. Metab. 96 (2): 296–307. doi:10.1210/jc.2010-1024. PMID 21147889.

[pmid2164530-11] Moreira AC, Leal AM, Castro M (1990). "Characterization of adrenocorticotropin secretion in a patient with 17 alpha-hydroxylase deficiency". J. Clin. Endocrinol. Metab. 71 (1): 86–91. doi:10.1210/jcem-71-1-86. PMID 2164530.

[pmid999330-12] Heremans GF, Moolenaar AJ, van Gelderen HH (1976). "Female phenotype in a male child due to 17-alpha-hydroxylase deficiency". Arch. Dis. Child. 51 (9): 721–3. PMC 1546244. PMID 999330.

[pmid226795-13] Biglieri EG (1979). "Mechanisms establishing the mineralocorticoid hormone patterns in the 17 alpha-hydroxylase deficiency syndrome". J. Steroid Biochem. 11 (1B): 653–7. PMID 226795.

[pmid8929268-14] Saenger P (1996). "Turner's syndrome". N. Engl. J. Med. 335 (23): 1749–54. doi:10.1056/NEJM199612053352307. PMID 8929268.

[pmid25813279-15] Bastian C, Muller JB, Lortat-Jacob S, Nihoul-Fékété C, Bignon-Topalovic J, McElreavey K, Bashamboo A, Brauner R (2015). "Genetic mutations and somatic anomalies in association with 46,XY gonadal dysgenesis". Fertil. Steril. 103 (5): 1297–304. doi:10.1016/j.fertnstert.2015.01.043. PMID 25813279.

[pmid4432067-16] Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE (1974). "Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism". Science. 186 (4170): 1213–5. PMID 4432067.

[pmid11344932-17] Schnitzer JJ, Donahoe PK (2001). "Surgical treatment of congenital adrenal hyperplasia". Endocrinol. Metab. Clin. North Am. 30 (1): 137–54. PMID 11344932.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Amenorrhea}}
 {{CMG}}; {{AE}}
 == Overview ==
@@ Line 34: / Line 34: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Mullerian agenesis<ref name="pmid11023205">{{cite journal |vauthors=Folch M, Pigem I, Konje JC |title=Müllerian agenesis: etiology, diagnosis, and management |journal=Obstet Gynecol Surv |volume=55 |issue=10 |pages=644–9 |year=2000 |pmid=11023205 |doi= |url=}}</ref>'''
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
@@ Line 52: / Line 52: @@
 ! style="background: #DCDCDC; padding: 5px; text-align: center;" |3-beta-hydroxysteroid dehydrogenase type 2 deficiency
 | style="background: #F5F5F5; padding: 5px;" |'''↑'''
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 70: / Line 70: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Androgen insensitivity syndrome<ref name="pmid15237040">{{cite journal |vauthors= |title=Current evaluation of amenorrhea |journal=Fertil. Steril. |volume=82 |issue=1 |pages=266–72 |year=2004 |pmid=15237040 |doi=10.1016/j.fertnstert.2004.02.098 |url=}}</ref>'''
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |↓
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 88: / Line 88: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Kallmann syndrome<ref name="pmid7641400">{{cite journal |vauthors=Albanese A, Stanhope R |title=Investigation of delayed puberty |journal=Clin. Endocrinol. (Oxf) |volume=43 |issue=1 |pages=105–10 |year=1995 |pmid=7641400 |doi= |url=}}</ref>'''
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 106: / Line 106: @@
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Turner syndrome<ref name="pmid15371580">{{cite journal |vauthors=Sybert VP, McCauley E |title=Turner's syndrome |journal=N. Engl. J. Med. |volume=351 |issue=12 |pages=1227–38 |year=2004 |pmid=15371580 |doi=10.1056/NEJMra030360 |url=}}</ref>'''
 | style="background: #F5F5F5; padding: 5px;" |
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 122: / Line 122: @@
 |-
 |
-| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[17-alpha-hydroxylase deficiency]]'''
+![[17-alpha-hydroxylase deficiency]]
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
 |-
 |'''Secondary amenorrhea'''
-| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Primary ovarian insufficiency<ref name="pmid19196677">{{cite journal |vauthors=Nelson LM |title=Clinical practice. Primary ovarian insufficiency |journal=N. Engl. J. Med. |volume=360 |issue=6 |pages=606–14 |year=2009 |pmid=19196677 |pmc=2762081 |doi=10.1056/NEJMcp0808697 |url=}}</ref>'''
+|'''Primary ovarian insufficiency<ref name="pmid19196677">{{cite journal |vauthors=Nelson LM |title=Clinical practice. Primary ovarian insufficiency |journal=N. Engl. J. Med. |volume=360 |issue=6 |pages=606–14 |year=2009 |pmid=19196677 |pmc=2762081 |doi=10.1056/NEJMcp0808697 |url=}}</ref>'''
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
 |-
 |
-| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Hypothyroidism<ref name="pmid14575026">{{cite journal |vauthors=Kalro BN |title=Impaired fertility caused by endocrine dysfunction in women |journal=Endocrinol. Metab. Clin. North Am. |volume=32 |issue=3 |pages=573–92 |year=2003 |pmid=14575026 |doi= |url=}}</ref>'''
+|'''Hypothyroidism<ref name="pmid14575026">{{cite journal |vauthors=Kalro BN |title=Impaired fertility caused by endocrine dysfunction in women |journal=Endocrinol. Metab. Clin. North Am. |volume=32 |issue=3 |pages=573–92 |year=2003 |pmid=14575026 |doi= |url=}}</ref>'''
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
 |-
 |
-| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Hyperprolactinemia<ref name="pmid15024895">{{cite journal |vauthors=Pickett CA |title=Diagnosis and management of pituitary tumors: recent advances |journal=Prim. Care |volume=30 |issue=4 |pages=765–89 |year=2003 |pmid=15024895 |doi= |url=}}</ref>'''
+|'''Hyperprolactinemia<ref name="pmid15024895">{{cite journal |vauthors=Pickett CA |title=Diagnosis and management of pituitary tumors: recent advances |journal=Prim. Care |volume=30 |issue=4 |pages=765–89 |year=2003 |pmid=15024895 |doi= |url=}}</ref>'''
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
 |-
 |
-| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Polycystic ovary syndrome<ref name="pmid12434783">{{cite journal |vauthors= |title=ACOG practice bulletin clinical management guidelines for obstetrician-gynecologists. Number 40, November 2002 |journal=Obstet Gynecol |volume=100 |issue=5 Pt 1 |pages=1045–50 |year=2002 |pmid=12434783 |doi= |url=}}</ref>'''
+|'''Polycystic ovary syndrome<ref name="pmid12434783">{{cite journal |vauthors= |title=ACOG practice bulletin clinical management guidelines for obstetrician-gynecologists. Number 40, November 2002 |journal=Obstet Gynecol |volume=100 |issue=5 Pt 1 |pages=1045–50 |year=2002 |pmid=12434783 |doi= |url=}}</ref>'''
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
 |-
 |
-| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Asherman's syndrome<ref>{{cite book | last = Fritz | first = Marc | title = Clinical gynecologic endocrinology and infertility | publisher = Wolters Kluwer Health/Lippincott Williams & Wilkins | location = Philadelphia | year = 2011 | isbn = 978-0781779685 }}</ref>'''
+|'''Asherman's syndrome<ref>{{cite book | last = Fritz | first = Marc | title = Clinical gynecologic endocrinology and infertility | publisher = Wolters Kluwer Health/Lippincott Williams & Wilkins | location = Philadelphia | year = 2011 | isbn = 978-0781779685 }}</ref>'''
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
-| style="background: #F5F5F5; padding: 5px;" |
+|
 |}

Amenorrhea differential diagnosis: Difference between revisions

Revision as of 14:38, 25 September 2017

Overview

Differentiating Diseases with Amenorrhea from each other

References

Navigation menu